Skip to main content
Log in

Blinatumomab

Immune effector cell-associated neurotoxicity syndrome

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Urbino I, et al. Life-threatening complications and intensive care unit management in patients treated with blinatumomab for B-cell acute lymphoblastic leukemia. Critical Care 28 : 1-3, Jan 2024. Available from: URL: https://dx.doi.org/10.1186/s13054-023-04787-x

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Blinatumomab. Reactions Weekly 1997, 37 (2024). https://doi.org/10.1007/s40278-024-53718-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-53718-2

Navigation